Cramer's 'Mad Money' Recap: Nvidia on Spec - Personal Finance - Mad Money Recap - ATK - BA: "'It's vital that you hold some high-risk stocks as part of a diversified portfolio,' he said, and he offered CV Therapeutics (CVTX - Cramer's Take - Stockpickr - Rating) and Nvidia (NVDA - Cramer's Take - Stockpickr - Rating) as examples.
Cramer added CVTX to his biotech speculative buy list, calling it a little $11 stock and a 'battleground.' It makes small molecule drugs for cardiovascular diseases, and as of May 10, 36% of the float had been sold short.
However, 'the bear case doesn't hold up under any scrutiny,' he assured people.
There are two ways market players can win here: Either the earnings explode, bringing CVTX's price to the mid-$20s, or it gets taken over, Cramer said. "